Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Director
-
Stock Symbol
-
ZBIO on Nasdaq
Patrick G. Enright - trading volume in the past year for Zenas BioPharma, Inc.
Holdings reported by Patrick G. Enright for Zenas BioPharma, Inc.
| Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
775K |
$13.2M |
$17.00 |
Sep 16, 2024 |
Indirect |
|
|
| Stock Option (Right to Buy) |
37K |
|
|
Sep 12, 2024 |
Direct |
Common Stock |
|
| Series B Convertible Preferred Stock |
0 |
|
|
Sep 16, 2024 |
Indirect |
Common Stock |
|
| Series C Convertible Preferred Stock |
0 |
|
|
Sep 16, 2024 |
Indirect |
Common Stock |
|
Transactions reported by Patrick G. Enright for Zenas BioPharma, Inc.
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.